RACHEL LANDREM: Open Payments
NPI 1225757040 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,413 in 143 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,341 · 2025 $2,413
Food & beverage: $2,314Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $930 |
| Janssen Biotech, Inc. | 21 | $396 |
| Madrigal Pharmaceuticals | 11 | $240 |
| Ardelyx, Inc. | 17 | $149 |
| QOL Medical, LLC | 5 | $96 |
| PFIZER INC. | 5 | $91 |
| Gilead Sciences, Inc. | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 7 | $76 |
Products named: RINVOQ, TREMFYA, SKYRIZI, REZDIFFRA, IBSRELA, CREON, LINZESS, Sucraid.
Industry payments across LA — which companies pay providers there.
